Warner Chilcott (US), LLC et al v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01471 (E.D. Tex. Oct. 24, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court are the parties’ objections to the Magistrate Judge’s Report and Recommendation. Dkts. 260 -62. For the reasons explained below, the objections are overruled and the Report and Recommendation is adopted, with the limited exception that Defendants ’ counterclaims as to validity and delisting are carried and stayed, pending a final and non -appealable judgment as to n on-infringement, as more fully described herein.